Analysts' Actions -- Bristol-Myers, Merck, United Technologies and More

RATINGS CHANGES

Ambac (AMBC) was downgraded to sell from neutral at MKM Partners. $10 price target. The company is facing increased regulatory scrutiny, MKM said. 

Bristol-Myers Squibb (BMY) was upgraded to buy at Jefferies. $69 price target. The company has an attractive clinical pipeline, but trades at a discount to its peers, Jefferies said. 

Blackstone (BX) was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: BX.

Dexcom (DXCM) was upgraded to outperform from perform at Oppenheimer. $84 price target. The company is focused on big, long-term opportunities, Oppenheimer said. 

Merck (MRK) was downgraded to underperform at Jefferies. $48 price target. Earnings estimates are below consensus, as Keytruda should continue to face pressure, Jefferies said. 

Realogy (RLGY) was upgraded to outperform from neutral at Wedbush. $32 price target. The company is trading at a depressed valuation and is leveraged to rising existing home sales, Wedbush said. 

United Technologies (UTX) was upgraded to outperform from neutral at Credit Suisse. $125 price target. Profit margin and earnings momentum are near a bottom, Credit Suisse said. 

Williams (WMB) was upgraded to overweight from equal-weight at Morgan Stanley. $35 price target. Business has stabilized and management should now focus on the cost of capital, Morgan Stanley said. 

This article was written by a staff member of TheStreet.

More from Stocks

Tilray and Other Pot Stocks are Smokin' Hot Again

Tilray and Other Pot Stocks are Smokin' Hot Again

Dunkin' Donuts Drops 'Donuts' from Its Name (But Not Its Shelves)

Dunkin' Donuts Drops 'Donuts' from Its Name (But Not Its Shelves)

Bonds at Important Level as Market Awaits Fed Decision

Bonds at Important Level as Market Awaits Fed Decision

A Rally in This Sector Could Push the S&P 500 to 3,000

A Rally in This Sector Could Push the S&P 500 to 3,000

Striking Options: Fed, S&P 500, Crude Oil

Striking Options: Fed, S&P 500, Crude Oil